Latest News

Germany to pump €1bn into breakthrough innovation

German Research Minister Anja Karliczek and Economics Minister Peter Altmaier make a joint statement on the founding of the Agency for Jump Innovations following the meeting of the Federal Cabinet. © BMBF / Hans-Joachim Rickel


by tg

Germany’s government announced that it will create an agency for breakthrough ("jump") innovation to foster technology transfer of risky research projects with high market potential into products.

The German agency precede EU plans to create a similar EU agency within its next research framework programme starting in 2021. The agency will be funded with roughly €1bn over 10 years.

The move is intented to keep value creation in Germany.  The idea for such an agency is lent from the US agency DARPA (Defense Advanced Research Projects Agency), which was founded by President Dwight D. Eisenhower in the 1950ies to support commercialisation of groundbreaking inventions such as the Internet, GPS or driverless vehicles. Besides Germany, Sweden and Switzerland have already established innovation agencies for non-military purposes. 

The German agency is set to start next year. According to Germany’s minister for economics, Peter Altmaier, a first call will seek for 3 to 4 promising artificial intelligence projects.

Cellestia Biotech AG attracts Series A financing

The company, which is in Phase I testing of CB-103 in 25 patients with advanced blood cancers and solid tumours, said it will use the proceeds to...

MEPs back €120bn budget for Horizon Europe

While the EU will miss its target to raise total public and private R&D spending in the EU to 3% of GDP by 2020 - in 2017 the EU average was...

Staten Biotechnology in $430m deal with Novo Nordisk

Under the agreement, Dutch Staten Biotechnology B.V. and Novo Nordisk A/S will collaborate to co-develop Staten's preclinical dyslipidemia...

BioNtech swallows MAB Discovery antibody unit

Under the terms of the agreement, BioNTech will acquire all assets, employees and proprietary know-how for mAb generation from MAB Discovery....

Clariant inks cellulosic biodiesel pact with ExxonMobil/REG

The companies said the goal of their partnership was to combine Clariant’s sunliquid® microbial cellulose degradation technology with REG’s...

Arvelle Therapeutics raises $180m in Series A financing

It's one of the largest Series A financings for a European biotech company. A global syndicate of investors led by LSP and including...

Anaveon bags CHF35m series A financing

Syncona Ltd led the financing round with an CHF28m investment acquiring a 47% stake in the Swiss immuno-oncology specialist, that got seed financing...